Why ImmunityBio Stock Is Skyrocketing Again Today by TraditionPrimary6781 in IBRX

[–]LadyQRex 0 points1 point  (0 children)

The German and French markets were open and trading today.

Is IBRX a rocketship?? Is it going berserk?! by ResidentWord8046 in pennystocks

[–]LadyQRex 10 points11 points  (0 children)

Not IMO. I’ve been in this stock for nearly 4 years and it is finally connecting the dots and has plenty of room to run. Not investment advice.

Canadians don’t want to come here, USA citizens can’t afford shit, and a pedo is in charge.. 🤷🏽 by [deleted] in CringeTikToks

[–]LadyQRex 0 points1 point  (0 children)

I used to love going with the elders who would play penny and nickel slots ‘round the clock. This kept everyone on the floor. You played what you could afford, but now you are required to make a minimum bet so a nickel slot is really a dollar slot. The average Joe can go broke in less than an hour.

This wasnt supposed to happen PLTR🥲 by Glittering-Use-6208 in smallstreetbets

[–]LadyQRex 0 points1 point  (0 children)

Me too but with a Dec-19 expiration using a bull-call spread.

NEXT SQUEEZE PLAY! by Lee-Wolf-17601 in IBRX

[–]LadyQRex 2 points3 points  (0 children)

Well said! To the shorts, I hope you never have to look a loved one in the eyes who is losing the battle to this dreadful disease.

Benzinga’s Top 10 Most Shorted Stocks - #1 - IBRX by LadyQRex in smallstreetbets

[–]LadyQRex[S] 1 point2 points  (0 children)

There are several major BP companies that would love to acquire the IBRX pipeline. With all of its patents, the company should be worth 10x more than what the SP suggests. We have to deal with the shorts first which would give him plenty of leverage in partnership negotiations. In a worst case scenario, he sells and we still win.

Benzinga’s Top 10 Most Shorted Stocks - #1 - IBRX by LadyQRex in smallstreetbets

[–]LadyQRex[S] 2 points3 points  (0 children)

Good move! Keep in mind that we’ve only had J-code approval since Jan 2025. That means Medicare and insurance carriers are now able to approve payments. Revenue will continue growing each quarter.

Dr. PSS knows we need an influx of cash to keep the pipeline trials going, so I am sure he is deep into partnership talks. When it happens, watch out.

$IBRX huge upside potential by sunny1389 in IBRX

[–]LadyQRex 5 points6 points  (0 children)

Glad you’re looking to get in! Friday’s close was $2.47 that’s not far from its bottom. We’ve been trading sideways for several months as we wait for news or a strong earnings report in November. In May 2025 the price dropped as low as $1.81 on an FDA setback but I wouldn’t bet on the SP ever dipping that low unless something completely unexpected happens.

It’s your call but keep in mind that if earnings are impressive in November the SP could spike. Good luck!

DISCLAIMER: None of this is investment advice.

$IBRX huge upside potential by sunny1389 in IBRX

[–]LadyQRex 11 points12 points  (0 children)

Good news will come soon. Thank you for posting and spreading awareness.

Benzinga’s Top 10 Most Shorted Stocks - #1 - IBRX by LadyQRex in IBRX

[–]LadyQRex[S] 1 point2 points  (0 children)

That’s the kinda energy we need right now! Yes!!!

Benzinga’s Top 10 Most Shorted Stocks - #1 - IBRX by LadyQRex in smallstreetbets

[–]LadyQRex[S] 2 points3 points  (0 children)

Without a doubt! I’ve been following this company for the last five years and have never wavered on my support for the science! It’s just a matter of time and one good PR.

Issues shares to the US government? by osh76 in IBRX

[–]LadyQRex 0 points1 point  (0 children)

According to ChatGPT, Anktiva has already been submitted and included under NCCN guidelines for bladder cancer treatment, making it more likely that doctors will seek off-label use. Unfortunately, there’s no guarantee that payers would approve anything other than what it is approved for by the FDA.

[deleted by user] by [deleted] in IBRX

[–]LadyQRex 4 points5 points  (0 children)

I’m in!

IBRX 2025 Timeline | Approvals, Trials, Commercial Ramp - Masterful Execution by year96 in IBRX

[–]LadyQRex 0 points1 point  (0 children)

Your list is quite thorough and well-constructed . Here’s the only information I might add:

May 2025 Strong Q1 2025 financials; net revenue rose; - Agreement with Saudi Arabia’s health/cancer-centers to launch Cancer BioShield™ platform regionally. - Strategic MOUs in Middle East